显微镜领域人工智能市场
显微镜领域人工智能市场：2026年市场规模约为15.1亿美元，2031年市场规模约为29.8亿美元；预测期复合年增长率为14.53%；当前最大市场为北美；增长最快的市场为亚太地区。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
待补内容：缺少驱动因素核心结论
显微镜领域人工智能市场：2026年市场规模约为15.1亿美元，2031年市场规模约为29.8亿美元；预测期复合年增长率为14.53%；当前最大市场为北美；增长最快的市场为亚太地区。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 14.53% | 机构预测 |
| 市场规模 | 2026 | USD 1.51 billion | 机构预测 |
| 市场规模 | 2031 | USD 2.98 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | pathology | 2025 | 42.400% |
关键结论
- application 维度中，pathology 在 2025 年的公开份额为 42.4%。
主要参与者
- Carl Zeiss AG
- Leica Microsystems GmbH
- Nikon Corporation
- Evident Corporation
- Hamamatsu Photonics K.K.
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Limited Clinical Validation Across Diverse Stains, Tissues, And Imaging Protocols | -1.800% | Global, strongest in North America and EU regulatory settings | Short term (≤ 2 years) |
| High Data Standardization And Annotation Burden For Model Training | -1.400% | Global, with structural data-access barriers in China and India | Medium term (2-4 years) |
| Cybersecurity And Data Residency Concerns For Cloud-Connected Microscopy | -0.900% | North America, the EU, and MEA | Medium term (2-4 years) |
| Budget Pressure From Instrument Refresh Cycles And Fragmented Lab IT Procurement | -1.100% | Global, most pronounced in emerging markets | Long term (≥ 4 years) |
报告关注的关键问题
What is the expected value of AI microscopy by 2031?
The AI microscopy market is forecast to reach USD 2.98 billion by 2031, rising from USD 1.51 billion in 2026 at a 14.5% CAGR over 2026-2031.
Which region leads global revenue today?
North America led with 40.5% of global revenue in 2025, supported by strong pathology infrastructure, academic medical centers, and enterprise deployment activity.
Which region is growing the fastest through 2031?
Asia-Pacific is projected to grow the fastest at a 13.2% CAGR through 2031, helped by laboratory modernization, hospital expansion, and rising digital pathology adoption.
Which component is expanding the fastest?
Imaging software is the fastest-growing component, with an 18.3% CAGR through 2031, because new analytical capability can be added on top of existing scanner infrastructure.
Why is drug discovery becoming more important in this field?
Drug discovery is growing at 16.9% CAGR because AI imaging now supports high-content screening, translational workflows, and even regulated evidence generation in drug programs.
What is the biggest barrier to broader adoption?
The biggest barrier is still validation across different stains, tissues, scanners, and site-specific workflows, which makes scale-up slower even when algorithms perform well.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence